-
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China
17 Feb 2026 16:50 GMT
… lung cancer (NSCLC) accounts for approximately 85% of lung cancer … with adenocarcinoma.6
Approved drugs for lung cancer in China … small cell lung cancer in Korea. Transl Lung Cancer Res. … histological evolution of lung cancers acquiring resistance to EGFR …
-
Clinicopathological and Genomic Analysis of SMARCA4-Deficient Non-Small Cell Lung Cancer: A Retrospective Cohort Study
16 Feb 2026 13:41 GMT
… , family history of lung cancer, history of tuberculosis, … poorly differentiated adenocarcinoma, infiltrative adenocarcinoma, and adenocarcinoma with … therapeutics methods. Lung Cancer. 2024;192:107818 … -small cell lung cancer. Transl Lung Cancer Res. 2025 …
-
Preliminary Exploration of Fluvastatin Inhibiting Proliferation, Migration and Invasion of Lung Cancer Cells and Reversing Paclitaxel Resistance: Mechanism Exploration Based on Multi-Omics Analysis
16 Feb 2026 07:38 GMT
… Lung cancer is classified into small cell lung cancer and non-small cell lung cancer … ferroptosis in lung adenocarcinoma.12 Additionally, studies … non-small cell lung cancer. Lung Cancer. 2015;87(2 … : implications for lung cancer therapy. Lung Cancer. 2011;72( …
-
Bioinformatic Identification and Preliminary Validation of TP53, TGFB1, and NFE2L2 as Potential Ferroptosis-Related Regulators in Pancreatic Adenocarcinoma
16 Feb 2026 13:41 GMT
… mortality rate of pancreatic adenocarcinoma is mainly attributed … expression data for pancreatic adenocarcinoma (PAAD) were retrieved … Conditions
Five human pancreatic ductal adenocarcinoma (PDAC) cell lines … in non-small cell lung cancer. Nat Genet. 2015; …
-
Rising lung cancer in never smokers demands urgent research focus
12 Feb 2026 17:51 GMT
… the overwhelming majority of lung cancer screening resources are directed … used for smoking-related lung cancer, such as immunotherapy, … that lung cancer could be the cause.
"Lung cancer in … with lung cancer are more likely to develop an adenocarcinoma, …
-
Real-World Outcomes and Safety of PD-1 Blockade Rechallenge Strategies After Prior Immunotherapy in Advanced NSCLC: A Retrospective Cohort Study
17 Feb 2026 16:50 GMT
… lung cancer (NSCLC) accounts for approximately 85% of lung cancers … in 14 patients (adenocarcinoma cases). The PD … lung cancer (NSCLC): a subgroup analysis of ALTER0303 trial. Transl Lung Cancer … cell lung cancer: a retrospective exploratory study. Lung Cancer. …
-
Healthcare Costs and Trends of Multimorbidity in COPD Patients: A Population-Based Study in Singapore
16 Feb 2026 21:27 GMT
… increased lung cancer incidence, particularly epidermal growth factor receptor (EGFR)-mutant adenocarcinomas common … -K, Andarini S, et al. Lung cancer screening in Asia: an expert …
-
Causal Implication of CD52-Driven Immune Dysregulation in Sarcopenic Obesity: Integrating Mendelian Randomization and Multiomics Profiling
16 Feb 2026 07:38 GMT
… T cells in pancreatic ductal adenocarcinoma: a retrospective analysis. Ann Surg … value for non-small-cell lung cancer patients treated with immune checkpoint …
-
Osimertinib ± Savolitinib in MET-EGFR NSCLC Trial
15 Feb 2026 10:40 GMT
… landscape for non-small cell lung cancer (NSCLC), specifically targeting patients harboring … approximately 10-15% of lung adenocarcinomas in Western populations, and up … Laboratory of Translational Medicine in Lung Cancer (2017B030314120 [Y.L.W.]), the …
-
How Cell Metabolism Fuels the Immunosuppressive Tumor Environment
14 Feb 2026 13:31 GMT
… , CAFs found in pancreatic ductal adenocarcinoma may utilize different metabolic pathways … those found in breast or lung cancer, requiring researchers to map the …
About
© 1995-2026